Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Current Liabilities for the year ending March 31, 2024: USD 52.78 M

Yuki Gosei Kogyo Co., Ltd. Current Liabilities is USD 52.78 M for the year ending March 31, 2024, a -10.14% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Yuki Gosei Kogyo Co., Ltd. Current Liabilities for the year ending March 31, 2023 was USD 58.73 M, a 2.59% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Current Liabilities for the year ending March 31, 2022 was USD 57.25 M, a -3.04% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Current Liabilities for the year ending March 31, 2021 was USD 59.05 M, a 5.78% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Current Liabilities for the year ending March 31, 2020 was USD 55.82 M, a -6.60% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Materials
Industries
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 2, 2025

Any question? Send us an email